Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT

Background: The comparative efficacy, and cost-effectiveness, of imiquimod or podophyllotoxin cream, either alone or in combination with the quadrivalent HPV vaccine (Gardasil®, Merck Sharp & Dohme Corp., Merck & Co., Inc., Whitehouse Station, NJ, USA) in the treatment and prevention of recurrence o...

Descripció completa

Dades bibliogràfiques

Autors principals:	Richard Gilson, Diarmuid Nugent, Kate Bennett, Caroline J Doré, Macey L Murray, Jade Meadows, Lewis J Haddow, Charles Lacey, Frank Sandmann, Mark Jit, Kate Soldan, Michelle Tetlow, Emilia Caverly, Mayura Nathan, Andrew J Copas
Format:	Artigo
Idioma:	Inglês
Publicat:	NIHR Journals Library 2020-09-01
Col·lecció:	Health Technology Assessment
Matèries:	human papillomavirus anogenital warts podophyllotoxin imiquimod quadrivalent hpv vaccine randomised controlled trial
Accés en línia:	https://doi.org/10.3310/hta24470
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!